Supply chain middlemen ‘pocket half of US branded medicine spending’
Pharma Phorum
JANUARY 13, 2022
BRG – which says it aims to bring “clarity” to drug distribution and payment processes – said insurers, PBMs and government programmes received more than $141 billion in spending on brand medicines in 2020, up from $50 billion in 2013.
111 
Let's personalize your content